ProstaLund AB announced that the product Schelin Catheter has been registered and approved for sale in Switzerland. At the same time, the company has signed a couple of distribution agreements with some distributors. The first orders will be delivered during the current quarter.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.654 SEK | -4.39% | -43.62% | -59.88% |
16/05 | ProstaLund AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
08/04 | ProstaLund AB Presents Two New Studies with Schelin Catheter | CI |
1st Jan change | Capi. | |
---|---|---|
-59.88% | 46.78L | |
-5.43% | 18TCr | |
+4.30% | 11TCr | |
-3.09% | 6.83TCr | |
+5.86% | 5.22TCr | |
+8.15% | 4.43TCr | |
+7.52% | 4.27TCr | |
+25.54% | 3.25TCr | |
+17.85% | 2.6TCr | |
+1.00% | 2.59TCr |
- Stock Market
- Equities
- PLUN Stock
- News ProstaLund AB
- ProstaLund AB Announces Registration and Approval of Product Schelin Catheter for Sale in Switzerland